LIMN
Liminatus Pharma
LIMN
LIMN
10 hedge funds and large institutions have $2.28M invested in Liminatus Pharma in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$819K | |
| 2 | +$712K | |
| 3 | +$351K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$212K |
| 5 |
BlackRock
New York
|
+$148K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $819K |
|
|||
2
Geode Capital Management
Boston,
Massachusetts
| $712K |
|
|||
3
UBS Group
Zurich,
Switzerland
| $351K |
|
|||
|
4
State Street
Boston,
Massachusetts
| $212K |
|
|||
|
5
BlackRock
New York
| $148K |
|
|||
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $32K |
|
|||
|
TRCT
7
Tower Research Capital (TRC)
New York
| $5.66K |
|
|||
8
Barclays
London,
United Kingdom
| $2K |
|
|||
9
Bank of America
Charlotte,
North Carolina
| $735 |
|
|||
|
SS
10
SBI Securities
Tokyo,
Japan
| $580 |
|